Chinook Therapeutics, Inc.
(NASDAQ : ADRO)

... ...
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.15%122.980.0%$2605.58m
BNGOBioNano Genomics, Inc. 13.29%9.550.0%$1909.26m
GILDGilead Sciences, Inc. 6.66%67.551.0%$668.56m
CRSPCRISPR Therapeutics AG -1.19%197.500.6%$576.08m
AMGNAmgen, Inc. 1.18%248.401.3%$558.77m
NVAXNovavax, Inc. 3.92%132.4292.9%$487.14m
REGNRegeneron Pharmaceuticals, Inc. 3.24%534.692.7%$472.42m
ALXNAlexion Pharmaceuticals, Inc. 1.31%158.752.0%$463.44m
ILMNIllumina, Inc. 1.56%382.243.5%$364.85m
BIIBBiogen, Inc. 1.20%279.161.7%$339.01m
VRTXVertex Pharmaceuticals, Inc. 0.93%227.651.9%$330.75m
SRPTSarepta Therapeutics, Inc. 3.28%93.2813.8%$328.90m
OCGNOcugen, Inc. 5.01%2.330.0%$320.61m
BNTXBioNTech SE 0.90%102.500.0%$317.28m
PACBPacific Biosciences of California, Inc. 3.67%38.287.4%$264.84m

Company Profile

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.